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The parabrachial nucleus (PBN) is a key nucleus for the regulation of feeding behavior. Inhibitory
inputs from the hypothalamus to the PBN play a crucial role in the normalmaintenance of feeding
behavior, as their loss leads to starvation. Viscerosensory stimuli result in neuronal activationof the
PBN, however the origin and neurochemical identity of the excitatory neuronal input to the PBN
remain largely unexplored. Here we hypothesize that hindbrain glucagon-like peptide 1 (GLP-1)
neurons provide excitatory inputs to the PBN, activation of which may lead to a reduction in
feeding behavior. Our data, obtained from mice expressing the yellow fluorescent protein in
GLP-1-producing neurons, revealed that hindbrain GLP-1-producing neurons project to the lateral
PBN (lPBN). Stimulationof lPBNGLP-1 receptors (GLP-1R) reduced the intakeof chowandpalatable
food and decreased body weight in rats. It also activated lPBN neurons, reflected by an increase in
the number of c-Fos-positive cells in this region. Further support for an excitatory role of GLP-1 in
the PBN is provided by electrophysiological studies showing a remarkable increase in firing of lPBN
neurons after exendin-4 application. We show that within the PBN, GLP-1R activation increased
gene expression of two energy balance regulating peptides, calcitonin gene related peptide
(CGRP) and interleukin-6. Moreover, nearly seventy percent of the lPBN GLP-1 fibers innervated
lPBN CGRP neurons. Direct intra-lPBN CGRP application resulted in anorexia. Collectively, our
molecular, anatomical, electrophysiological, pharmacological and behavioral data provide evi-
dence for a functional role of the GLP-1R for feeding control in the PBN.
Glucagon-like peptide 1 (GLP-1), produced in intesti-nal L-cells and the nucleus of the solitary tract (NTS)
in thehindbrain, regulates bloodglucose and reduces feed-
ing behavior (1). Much is known about the mechanisms
underlying the glucoregulatory function of GLP-1, and
this ability of GLP-1 has already been utilized in the clinic.
Genetic and pharmacological data have established that
GLP-1 receptor (GLP-1R) activation reduces food intake
and conversely, that a reduction of activity at the GLP-1R
increases food intake. Although GLP-1 is a key player in
energy balance control, the mechanisms and neural sub-
strates engaged by GLP-1 to regulate food intake are only
beginning to be identified.GLP-1 neurons innervatemany
brain areas relevant for energy balance control (2, 3). Ini-
tially the literature has emphasized the hypothalamus as
the primary target for the feeding inhibition by GLP-1 (4,
5); however, the energy balance control system extends
beyond the hypothalamus. Subsequent studies indicate
that both local GLP-1 neuronal projections within the
NTS and far reaching projections to the mesolimbic ven-
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tral tegmental area and the nucleus accumbens are impor-
tant for the normal regulation of feeding (6–9). In addi-
tion, GLP-1R and its mRNA have been identified in the
pontine parabrachial nucleus (PBN) (10). Here we inves-
tigate the functional role of GLP-1 in this nucleus for feed-
ing control and the mechanisms involved.
The PBN integrates neural and possibly hormonal sig-
nals associatedwith gustatory properties of food aswell as
visceral satiety and illness signals. Many neuropeptides
central to feeding regulation act on PBN neurons to mod-
ulate feeding behavior. Melanocortin and prostaglandin
receptor ligands applied directly to the PBNdecrease feed-
ing behavior (11), while cannabinoid and -opioid recep-
tor ligands increase feeding (12, 13). The PBN is a critical
nucleus for the creation of taste associations, but only in
rodents; in primates, and presumably also humans, the
PBN mainly functions as a relay point for viscerosensory
inputs (14). Recently, interest in the PBN has been reju-
venated by data showing that GABAergic and glutama-
tergic inputs to the PBN are pivotal in the regulation of
feeding behavior. When the PBN glutamate/GABA input
balance is disturbed,mice stop eating anddie of starvation
(15–18), a finding that underscores the critical role of the
PBN in the regulation of feeding behavior.
The PBN receives direct projections fromNTS neurons
relaying taste and viscerosensory information in rodents
(19), but the neuropeptides that these fibers carry have yet
to be elucidated. It is well known that GLP-1 is produced
by cell bodies of the NTS, and that projections from these
cells reachmanyparts of thebrain.Here, utilizing aunique
mouse model that expresses a fluorescent protein in GLP-
1-producing neurons,we investigatewhether theseGLP-1
neurons also project to the PBN.
This study sought to determine whether the NTS GLP-
1-producing neurons project to the PBN, thereby provid-
ing a source of the endogenous ligand to the PBNGLP-1R.
We further evaluated whether the PBN GLP-1R plays a
role in feeding behavior control. Because treatments that
induce hypophagia drastically increase activity in the lat-
eral PBN (lPBN) neurons we evaluated whether central
GLP-1R stimulation can induce c-Fos protein expression
in the PBN and whether GLP-1R activation in the PBN
changes the electrical activity of the PBN neurons. Lastly
we identify potential downstream mediators of GLP-1R
activation in the PBN, which may include calcitonin gene
related peptide (CGRP) and interleukin-6 (Il-6). Collec-
tively our molecular, electrophysiological, pharmacolog-
ical and behavioral data provide evidence for a functional
role of GLP-1R in the PBN in the control of feeding be-
havior and identify the neurochemical mechanisms
involved.
Materials and Methods
Animals. Adult female and male mGLU-124 Venus yellow flu-
orescent protein transgenic mice (YFP-PPG mice; University of
Cambridge, United Kingdom (20)) were housed in plastic cages
with water and standard chow available ad libitum. Male
Sprague-Dawley rats (180–250 g at arrival and 450 g during the
drug administration tests, CharlesRiver,Germany)were housed
in a 12 hours light/dark cycle, in individual cageswith free access
to chow and water, except during the period of chocolate and
saccharine consumption.All studieswere carriedoutwith ethical
permissions from theAnimalWelfare Committee of the Institute
of ExperimentalMedicine (IEM, Budapest, Hungary) andGöte-
borg University, in accordance with legal requirements of the
European Community (Decree 86/609/EEC).
Surgery.Ratswere implantedwithaguide cannula targeting the
lPBN or the lateral ventricle (26 gauge; Plastics One, Roanoke,
VA) under isofluorane anesthesia as described previously (11,
21). The following coordinates were chosen: lateral ventricle:
1.6mm/-0.9mm/-2.5mm(midline/bregma/skull respectively),
with injector aimed 4.5 mm ventral to skull; lPBN 2.0 mm/-9.5
mm/4.5 mm, with injector aimed 6.5 mm ventral to skull. PBN
cannula placement was verified histologically post mortem by
injectionof India ink (0.2l volumematcheddrugdelivery in the
experiments). Only rats whose dye injection site was found
within the lPBN were included in the data analysis.
GLP-1 fiberdetection.Micewere anesthetizedwithketamine/
xylazine solution and perfused transcardially with heparinized
saline followed by fresh fixative solution (paraformaldehyde
(PFA, 4%) in 0.1 M phosphate buffer). The brains were col-
lected, coronal 25 m sections were cut using a cryostat, then
collected in tubes containing tissue storage solution consisting of
50mlglycerin, 50ml ethyleneglycol and100ml0.1Mphosphate
buffer (pH 7.5) and stored until use in 4°C. The sections were
washed (3 15minutes) in TNTwith Triton-X (0,1%) (Sigma-
Aldrich St. Louis, MO, USA). For CGRP visualization, the sec-
tions were incubated for two days in TNB blocking solution
(Perkin Elmer, Akron, Ohio, USA) with 1:2000Goat polyclonal
antibody toCGRP (ab36001,Abcam,Cambridge, UK). The sec-
tions were then washed in TNT with Triton-X (0,1%) and in-
cubated in TNB blocking solutionwith 1:1000Donkey antigoat
Alexa Fluor 568® (ab36001, Abcam). The cell nuclei were
stained with DAPI (1:5000; Life Technologies, Carlsbad, CA,
USA). The sections were then washed in TNT (2 15 minutes),
submerged in 0.1M PB and mounted on microscope slides (Su-
perfrost® Plus, Menzel) together with ProLong Gold Antifade
(Life Technologies). The GLP-1 fibers were visualized with a
confocal microscope (LSM 700; Carl Zeiss, Oberkochen, Ger-
many). LPBN and mPBN DAPI-labeled cells and lPBN CGRP-
positive cells receiving GLP-1 innervation were quantified from
at least 4 25 m sections per brain. Triple channel confocal
images (to cover the entire PBN) were generated with a Plan
Fluor 20/0.75 lens and a solid-state laser. A tile scan of 3  3
tiles was obtained from the center of the lPBN and mPBN re-
spectively. Neurons were considered CGRP-labeled when their
stainingwas clearly above background and their cell nucleuswas
in the plane of image. Innervation of cells in the PBN by GLP-1
fibers was determined by switching between green- and blue-
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channel images (for quantification of GLP-1 innervated cells in
mPBN and lPBN) and red-, green- and blue-channel images (for
colocalization of GLP-1 fibers with CGRP-labeled neurons).
Food intake and saccharine drinkingmeasurements after
lPBN GLP-1R activation. Consumption of 1) chocolate pel-
lets (n 11), 2) 0.1% saccharine (n 12) and 3) chow (n 11)
wasmeasured in three groupsof rats unilaterally infused (0.2L)
with a selective and potent GLP-1R agonist Exendin-4 (Ex-4;
Tocris, Bristol, UK, 0.1 and 1 g) or vehicle (aCSF; Tocris) into
the lPBN. All injections were performed early in the light cycle.
Rats were exposed to both saccharine solution and chocolate
pellets on at least 6 occasions before the test to achieve a stable
intake and reduce the novelty of the food.Additionally 24h body
weight change was measured (n 11) in the third group of rats.
Rats had free access to water at all times and to chow at all times
except during the period of chocolate and saccharine intake
measurement.
Food intake and body weight measurements after lPBN
GLP-1R blockade. Consumption of chow was measured in
rats (n  12) unilaterally infused (0.3 L) with a selective
GLP-1R antagonist Exendin-9 (Ex-9; Tocris, 20 g) or vehicle
(aCSF; Tocris) into the lPBN. Bodyweight changewasmeasured
overnight, 16h after drug injections. Injections were performed
60minutes before dark onset. Rats had free access towater at all
times and to chow at all times except 5h prior to injections (dur-
ing the light cycle); this was done to ensure equal levels of satiety
at the start of the experiment. A similar experimental designwas
used when testing the effects of intra-lPBN injected CGRP (Toc-
ris, 3.8 g) or vehicle (aCSF).
Loose-patch clamp electrophysiology. Rats were anesthe-
tized using Isoflurane inhalation. The brainwas removed rapidly
and immersed in ice-cold sodium-free solution (22). Acute 300
m-thick coronal slices containing the lPBNwere preparedwith
a VT-1000S vibratome (Leica GmBH,Wetzlar, Germany) in the
sodium-free solution and then equilibrated in normal aCSF
(naCSF, in mM: NaCl 135, KCl 3.5, NaHCO3 26, MgSO4 1.2,
NaH2PO41.25,CaCl2 2.5, glucose 10, bubbledwithO2/CO2).
Loose-patch clampmeasurements to record action currentswere
carried out as described earlier (23) with slight modifications.
Briefly, pipette potentialwas held at 0mV, pipette resistance 1–2
M, resistance of loose-patch seal 7–40 M. The pipette solu-
tion contained (in mM): NaCl 123, KCl 3.5, CaCl2 2.5, MgCl2
1.3, HEPES 10, glucose 10 (pH  7.3 with NaOH). lPBN was
identified under microscopic control and large ovoid cells of this
area (24) were chosen for recordings. Measurements were car-
ried out with an initial control recording (4 minutes), then in the
first experimental groupof neuronsEx-4 (1M, (25))was added
to thenaCSFbya single bolus into the recording chamber and the
recording continued for a subsequent 11 minutes. In a second
experimental group of neurons the GLP-1-receptor antagonist
Ex-9 (1 M, (25), Tocris) was applied after the initial recording
of basal firing. Ex-9was then present in the naCSF continuously.
10 minutes after starting Ex-9 application, firing was recorded,
then Ex-4 was added and the recording continued. Each neuron
served as its own control when drug effects were evaluated.
cFos expression. Treatment: On the day of experiment rats
were injected with Ex-4 (0.3 g in 1 l) or aCSF (1 l) into the
lateral ventricle (n3–4per treatment group).Ratswere treated
and sacrificed during the light cycle. Rats had ad libitum access
to food throughout the study. Ninety min following the injec-
tions, all of the rats were anesthetized with ketamine-xylazine
solution and transcardially perfused with heparinized saline so-
lution, followed by 4%PFA in 0.1MPB. Immunocytochemistry
for detection of c-Fos-protein in brain sections: Immunohisto-
chemical detection of c-Fos protein was performed as described
previously (26). Briefly: coronal sections (40 m) were cut on a
cryostat through the lPBN and every third section collected into
PB. Endogenous peroxidaseswere deactivated and sectionswere
incubated with a rabbit polyclonal anti-Fos antibody (Ab-5,
PC-38 Calbiochem, CN Biosciences UK, Nottingham). Bound
antibody was detected with peroxidase-labeled goat antirabbit
IgG (Vector Laboratories Ltd, Peterborough,UK) and visualized
using a nickel-intensified diaminobenzidine reaction giving a
purple–black precipitate within cell nuclei. PBN-containing
brainstem sectionswere viewedunder amicroscope and all c-Fos
positive cells were counted in the lPBN by an experimenter
blinded to the conditions.Datawere expressedasaverageof total
c-Fos counts of all rats; total number per rat was calculated by
adding total number of c-Fos positive cells from the left and right
lPBN.
RNA isolation andmRNAexpression. PBNgene expression
levels were measured after lateral ventricle injection of Ex-4 or
vehicle (aCSF) in two separate groups of rats. One group was
restricted to 10 g (50% of average overnight intake) of chow
overnight and the secondwas allowed to eat ad libitum (n 6–9
per treatment group). The following genes were examined:
Calca, Gabr, Gad1, Grin2b, Il1b, Il6, and Mc4r. They were
selected because of their reported role in feeding regulation in
PBN or their connection to GLP-1. Ninety minutes after Ex-4 or
aCSF injection the brainswere rapidly removed and the PBNwas
dissected using a brain matrix, frozen in liquid nitrogen and
stored at –80°C. Individual brain samples were homogenized in
Qiazol (Qiagen, Hilden, Germany) using a TissueLyzer (Qia-
gen). Total RNAwas extracted using RNeasy Lipid TissueMini
Kit (Qiagen) with additional DNAse treatment (Qiagen). RNA
quality and quantity were assessed by spectrophotometric mea-
surements (Nanodrop 1000, NanoDrop Technologies, USA).
For cDNA synthesis iScript cDNA Synthesis kit (BioRad) was
used. Real-time RT PCRwas performed using TaqMan® probe
andprimer sets for target genes chosen fromanon-line catalogue
(Applied Biosystems; reference numbers were as follows: Actb-
Rn00667869_m1, Mc4r-Rn01491866_s1, Calca-
Rn01511353_g1, Grin2b-Rn00680474_m1, Gabrd-
Rn01517017_g1, Gad1-Rn00690300_m1, IL1b-
Rn00580432_m1, IL6-Rn01410330_m1). Gene expression
values were calculated based on the [GRAPHIC][GRAPHIC]Ct
method (27), where the vehicle-injected groupwas designated as
the calibrator (results shown in Figure 5). Beta actin was used as
reference gene.
Statistical analysis.All the data are presented asmean Stan-
dardError of theMean (SEM). For electrophysiology groupdata
were expressed as mean  SEM and percentage change in the
frequency of the firing rate due to the application of the Ex-4 or
the Ex-9was calculated. Each electrophysiological experimental
group contained 10 recorded cells from six to seven animals.
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Patch clamp recordings were stored and analyzed off-line. Event
detection in the recordings was performed using the Clampfit
module of PClamp 9.2 software (Molecular Devices Co.). For
electrophysiology, c-Fos results and feeding data statistical sig-
nificance was analyzed using Student’s t test or one or two-way
ANOVA when appropriate (GraphPad Software, Inc., San Di-
ego, CA). The “p” values  0.05 were considered statistically
significant.
Results
GLP-1 fibers in the PBN. Fluorescent YFP– preprogluca-
gon (PPG) neurons were detected at the caudal region of
the nucleus of the solitary tract (NTS) of YFP–PPG mice
(Figure 1 A,B). Green YFP-immunoreactive axons were
found to closely appose blue DAPI-labeled cell bodies in
the lPBN (Figure 1 C,D). Over half (55%  1.2) of the
lPBN cell bodies were found to receive fibers from the
hindbrain GLP-1 neurons. The medial region of the PBN
was also found to receive YFP-immunoreactive fibers,
however to a lesser extent than the lPBN region (31% 
2.3 of the DAPI-positive mPBN cells were innervated by
GLP-1 fibers; Figure 1 E,F).
Food intake, saccharine drinking and body weight after
intra-lPBN GLP-1R stimulation. The goal of the in vivo
experimentswas todeterminewhetherGLP-1Ractivation
in the PBN can contribute to food intake reduction across
a variety of caloric, palatable and less palatable, as well as
noncaloric sweet liquid foods. PBN GLP-1R stimulation
via microinjection of a selective GLP-1R agonist Ex-4 sig-
nificantly reduced chocolate pellet consumption over the
2 hours period of measurement (Figure 2A). Intra-PBN
Ex-4 microinjection also reduced the amount of saccha-
rine drunk by a separate group of rats (Figure 2B; one-way
ANOVA: F(2, 35)5.96,P .008)without affectingwater
drinking (offered in parallel with saccharine). Moreover
the intake of normal chow (Figure 2C; one-way ANOVA:
F(2, 38)9.19,P .001) and bodyweight (Figure 2D; one-
way ANOVA: F(2, 35)10.5, P .001) were also reduced
when measured over a 24 hours period.
Food intake and body weight after intra-lPBN GLP-1R
blockade. Blockade of lPBNGLP-1 receptors resulted in a
significant increase in chow intake at 2 and 3h after Ex-9
injections and a significant increase in body weight mea-
sured overnight 16h after Ex-9 injection (Figure 3A-C).
PBNGLP-1Rstimulationresultsinincreasedfiringrateof
lPBN neurons.To test the hypothesis that Ex-4 influences
function of large ovoid neurons in the lPBN,we examined
the electrophysiological responseof theseneurons toEx-4.
In the first experimental group Ex-4 (1 M) was applied
and increased the firing rate significantly (330  60% of
the control; Figure 4A and B). The basal firing rate (with-
out any drugs) was 1.02  0.44 Hz (Figure 4A). In a
second experimental group Ex-4 was administered in the
presence of the GLP-1 antagonist, Ex-9 (1 M) and the
firing rate remained unaltered (135 52% from the firing
rate obtainedwithEx-9; Figure4CandD).This valuewas,
however, significantly different from that achieved with
Ex-4 alone (Figure 4E). Application of Ex-9 alone did not
affect the firing rate of the recorded neuron (115  34%
of the basal firing rate).
c-Fos protein expression. To confirm the electrophysiol-
ogy results from rat PBN slices in vivo we determined
whether a central injection of Ex-4 can activate PBN neu-
rons. Central GLP-1R stimulation via lateral ventricle in-
jection of Ex-4 increased the number of detected c-Fos-
positive cells in the lPBN (Figure 4F-G).
Gene expression. Central activation of GLP-1Rs resulted
in a62%increase in expressionofmRNAencodingCGRP
(Calca) (Figure 5A), an anorexic peptide that is expressed
in the intra PBN- and amygdala-projecting PBN neurons,
in ad libitum fed rats. The expression of the gene encoding
melanocortin receptor 4, the stimulation ofwhich in lPBN
Figure 5. Gene expression after central GLP-1R stimulation. In ad
libitum-fed rats GLP-1R activation by Ex-4 increased the mRNA
expression of the gene that encodes CGRP (Calca), without
significantly changing the mRNA expression of other genes previously
shown to be associated with changes in food intake in the PBN (A). In
overnight-fasted rats, Ex-4 did not significantly change the mRNA
expression of any of the genes measured (B). Ex-4 increased the
expression of IL6 (but not IL1), central mediators of GLP-1R-induced
anorexia in both ad libitum-fed (C) and fasted (D) rats. Data are
expressed as mean SEM. ** P  .01.
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was previously shown to result in anorexia, was not al-
tered. Similarly the expressionof genes encoding receptors
for N-methyl D-aspartate receptor subtype 2B (Grin2b)
and -aminobutyric acid (GABA) A receptor delta (Ga-
brd), as well as the gene encoding glutamate decarboxyl-
ase (Gad1) remained unchanged after Ex-4 treatment in
this experimental paradigm.We next determinedwhether
Ex-4 treatment increased the expression of IL1 and IL6,
two molecules that mediate a part of the anorexic effects
of Ex-4 in the hypothalamus and the hindbrain (28), and
showed that Ex-4 increased IL6, but not IL1 gene ex-
pression in the PBN in both ad libitum fed and food-de-
prived rats (Figure 5C-D). The following average
[GRAPHIC]Ct values (SEM) relative to -actin were
detected for ad libitum-fed rats: Calca (3.0  0.3, 2.3 
0.1, P .01),Gabrd (5.6 0.2, 5.6 0.2),Gad1 (5.2
0.2, 5.30.1),Grin2b (6.60.2, 6.40.1),Mc4r (9.0
0.3, 8.7 0.2), IL1  (9.2 0.2, 8.9 0.7), IL6 (11.9
0.2, 9.4 0.7, P .005); values are given for vehicle and
Ex-4 respectively. The following average [GRAPHIC]Ct
values relative to -actin were de-
tected for overnight food-restricted
rats: Calca (2.6  0.2, 2.7  0.1),
Gabrd (5.9 0.3, 5.2 0.3),Gad1
(5.60.3, 5.30.2),Grin2b (6.3
0.2, 6.4  0.1), Mc4r (8.9  0.2,
8.9  0.1), IL1 (8.5  0.1, 8.1 
0.4), IL6 (11.3 0.2, 9.1 0.5, P
.005); values are given for vehicle
and Ex-4 respectively.
Innervation of lPBNCGRP-positive
cells and effect of intra-lPBNCGRP
injections on food intake and body
weight.Guided by results indicating
an elevation in CGRP in the PBNwe
set out to determine whether the
GLP-1 fibers provide direct innerva-
tion to the lPBNCGRPneurons.Our
results indicate that most lPBN-pro-
jectingGLP-1 fibers innervateCGRP
positive cells and nearly half of the
CGRP-expressing cells in the lPBN
receive GLP-1 innervation (Figure 6
A-D). Furthermore we determined
whether elevated CGRP is sufficient
to alter food intake when applied di-
rectly and selectively to the lPBN. In-
tra-lPBN CGRP injections resulted
in a significant short term (1–2h)
food intake reduction (Figure 7A).
Food intake and body weight at 16h
after CGRP injections were not al-
tered (Figure 7B-C).
Discussion
Viscerosensory stimuli result in neu-
ronal activation of the PBN, but the
origin and neurochemical identity of
the excitatory neuronal input to the
Figure 1. GLP-1 innervation of the PBN. Fluorescent YFP– preproglucagon neurons (green) and
DAPI (nuclear stain, blue) in coronal sections through the PBN and the nucleus of the solitary
tract (NTS) of YFP–PPG mice. Micrographs showing the cell bodies of green YFP-immunoreactive
preproglucagon neurons (yellow arrows) in the NTS (A-B). Micrographs showing the lPBN (C-D),
and the region of the medial PBN (mPBN) just below the superior cerebellar peduncles (scp) (E-F).
Many green YFP-immunoreactive axons closely appose blue DAPI-labeled cell bodies in the lPBN.
White arrows indicate PBN cell bodies closely apposed by the GLP-1 fibers, while red arrows
indicate cell bodies in this region that were not apposed by the GLP-1 fibers. Insets in panels B,D
and F show the interaction at a single cell level. Central canal (cc). B,D and F show higher
magnification of areas in A,C and D, respectively.
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PBN remain largely unexplored. Here we provide data
implicating NTS-originating GLP-1-producing neurons
as one source of excitatory projections to the PBN.More-
over we demonstrate a functional role for parabrachial
GLP-1R activation in food intake control. Several lines of
evidence support this conclusion. Direct activation of
lPBN GLP-1R inhibited food intake
andbodyweight gain and conversely
lPBN GLP-1R blockade increased
food intake and body weight gain in
rats. These data indicate that lPBN
GLP-1R are necessary and sufficient
for food intake control. Stimulation
of PBN GLP-1R potently activated
PBN neurons, the activation of
which has previously been linked to
anorexia. The activation of lPBN
neurons via GLP-1R is underscored
both by an activational effect shown
via electrophysiology in rat brain
slices, and as increased activity of
PBN neurons, reflected by a signifi-
cant increase in the number of c-Fos-
positive cells in the lPBNafter central
Ex-4 injection.Moreover our neuro-
anatomical data implicate solitary
tract GLP-1 neurons as the source of
endogenous agonist for the GLP-1R
in the lPBN. Using a unique and well
validated Venus preproglucagon
(PPG) reportermouse (3, 20, 29, 30),
we show GLP-1-containing fibers in
the lPBN that are very likely to orig-
inate from the nucleus of the solitary
tract, the only major source of GLP-
1-producing neurons in the brain.
We also identify the downstream
neurochemicalmechanismof the an-
orexic effect of GLP-1 in the lPBN.
We show that in lPBN GLP-1R acti-
vation increased the expression of
CGRP, and most NTS-originating
GLP-1 fibers innervated lPBN
CGRP-producing neurons. More-
over increasedCGRPsignaling in the
lPBN induced anorexia and body
weight reduction.
Stimulation of GLP-1R in the
PBN increased the activity of neu-
rons in this area, as implied by our
electrophysiology and c-Fos data.
These data fit remarkably well with
previous studies showing that acti-
vation of neurons in the PBN, by re-
moval of the hypothalamic inhibi-
Figure 2. GLP-1R stimulation by Ex-4 in the lPBN reduces food intake and body weight. Intra-
lPBN delivery of Ex-4 reduced the consumption of chocolate pellets over the 2h period of data
collection (A), the amount of saccharine drank (but not water consumption) over 4h of data
collection (B), the 24h chow intake (C) and 24h body weight change (D). Data are expressed as
mean SEM. * P  .05, ** P  .01, *** P  .005. Representative photomicrograph of a
coronal section of rat brain at the level of the lPBN illustrating the microinjection site (encircled
area) for the behavioral experiments (left panel) and a schematic representation of the PBN (right
panel) (E).
Figure 3. GLP-1R blockade in the lPBN increases food intake and body weight. Intra-lPBN
delivery of Ex-9 increased chow intake at 2 and 3h after injection (A). Overnight chow intake
measured at 16h after Ex-9 injection was not altered (B). Ex-9 increased 16h body weight gain.
D,. Data are expressed as mean SEM. * P  .05
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tory GABAergic projections to the PBN or by optogenetic
activation of lPBN CGRP-expressing neurons, resulted in
hypophagia in mice (17, 18). Here we propose that acti-
vation of lPBN neurons by GLP-1 may be one of the ex-
citatory mechanisms that are uncovered when the hypo-
thalamic brake on the PBNneurons is removed. It is likely,
however, that GLP-1 transmission is not the only excit-
atory input to the PBN. Glutamatergic input may also be
involved, since knockdown of NMDA glutamate recep-
tors in the PBNcan prevent the hypophagia resulting from
GABAergic signal removal (16). Moreover GLP-1-pro-
ducing neuronsmay also produce a fast neurotransmitter,
which couldbe glutamate. Even thoughEx-4, a potent and
selective agonist forGLP-1R,wasused in the current study
our results are likely relevant for the GLP-1 peptide. In
fact, one previous report already indicated that central
injections of the native peptide, GLP-1, at the start of the
dark cycle in rats also induces c-Fos in the PBN (31).
Until recently, detection of the distribution of axonal
fibers of the GLP-1 neurons was hindered by the need to
use antibodies with neuronal tracers. This process was
facilitated by the creation of a transgenic mouse that ex-
presses a fluorescent signal, YFP, in
PPG-expressing cells; this mouse
model has beenused to identifyGLP-
1-producing neurons in the brain (3,
20, 29, 30). The transgenicYFP-PPG
mice offer an advantage over previ-
ousmethods in the formof the strong
YFP expression that allows for clear
visualization of the GLP-1-produc-
ing neuron axon fibers and termi-
nals. We detected dense YFP-posi-
tive axons at several levels of the
PBN. GLP-1 innervation was de-
tected throughout the rostro-caudal
extent of the PBN, with denser in-
nervation detected in the rostral re-
gion. YFP-positive fibers were also
found in the dorso-lateral, the exter-
nal-lateral and the medial PBN.
Thus, we show neuroanatomical
grounds for NTS GLP-1 neuron
communication to all levels of the
PBN. This potentially allows GLP-1
to influence a wide range of physio-
logical responses controlled by dif-
ferent nuclei of the PBN. One poten-
tial downside of using the YFP-mice
in the current study is that there may
be a species difference in the projec-
tion targets of the GLP-1-producing
neurons. For example, leptin control
of GLP-1 neurons has been shown to
differ between mice and rats (32). In
mice, leptin receptors are located di-
rectly on the GLP-1-producing neu-
rons in theNTS,whereas in rats, lep-
tin may only be influencing GLP-1
neuron activity indirectly (32).
Nonetheless some literature already
exists to support a direct, monosyn-
aptic, connectionbetween the caudal
Figure 4. Loose-patch clamp recordings of action currents in the neurons of the external lPBN.
Application of GLP-1 receptor agonist Ex-4 (1 M) in the extracellular solution increased the
firing rate (A and B). Extracellular administration of the GLP-1 receptor antagonist Exendin-9(9–
39) (Ex-9; 1 M), blocked this effect of Ex-4 (C and D). Histogram shows the relative percentages
of firing rate after application of Ex-4 with and without Ex-9 (E). Central GLP-1R stimulation by
lateral ventricle injection of Ex-4 increased c-Fos activation in the PBN. Quantified
immunoreactivity of Fos positive neurons in the PBN after Ex-4 treatment in ad libitum fed rats (F)
and representative images of the c-Fos study (G). Data are expressed as mean SEM. C-Fos data
were expressed as average of total c-Fos count of all rats; total number per rat was calculated by
adding total number of c-Fos positive cells from the left and right lPBN. Each electrophysiological
experimental group contained 10 recorded cells from 6 to 7 animals. * P  .05.
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NTS and the PBN in a rat. Indeed, it seems that PBN,
especially the lateral subdivisions, receives very dense in-
nervation from the NTS also in the rat (2). Innervation
from the NTS was shown to overlap with GLP-1-positive
terminals and a retrograde tracer injected into the lPBN
was indicated to colocalize with NTS GLP-1 producing
neurons in a rat (2, 33). Combined with other data show-
ing expression of GLP-1R in the rat PBN (10) and the
strong behavioral effect of GLP-1R activation in this spe-
cies, direct projection to the PBN from the NTS seems
rather likely in the rat.
GLP-1 activation in the lPBN suppressed chow intake,
intake of palatable chocolate pellets, and also intake of
noncaloric saccharine solution. This indicates that
GLP-1R signaling in the lPBN can reduce food intake
across the palatability and caloric density spectrum. Im-
portantly PBN Ex-4 injections did not reduce water in-
take. Collectively these data indicate that PBNGLP-1 sig-
naling may interact with the caloric
density, taste and hedonic properties
of food.ThePBNisa crucial relay for
the hedonic value of food; lesion of
the PBN blunts nucleus accumbens
dopamine elevation in response to
palatable food (34). Moreover one
recent study indicates that lPBN-di-
rected Ex-4 injections reduce high-
fat food intake and suppress the mo-
tivation to work for a high-fat
reward in rats (33). Both taste and
caloric value, processed in the PBN,
may contribute to the PBN-relayed
dopamine response. Activation of
PBN neurons, akin to that observed
here with Ex-4, can reduce the hedo-
nic properties of food and inhibition
of PBN neurons by microinjections
of GABA-A receptor agonists into
the PBN increases hedonic responses
to oral sucrose (35).
The PBN is a heterogeneous nu-
cleus with at least twelve distinct
subnuclei and subdivisions of the
PBN can be clearly differentiated
based on their neuronal inputs and
outputs (36). The gustatory afferents
are represented in the medial subdi-
vision, and the viscerosensory, the
cardiovascular and the respiratory
functions in the lateral subdivision.
In the current study, the decision to
target the lPBN was based on the
idea that caudally located GLP-1
neurons are likely to project to the
viscerosensory lPBN rather than the
mPBN, since inputs from the caudal
viscerosensory NTS are segregated
from the gustatory inputs from the
rostral NTS to the medial PBN.
However the segregation of inputs
does not prevent some cross-com-
Figure 6. GLP-1 innervation of CGRP neurons in the lPBN. Many YFP-immunoreactive axons
(green) closely apposed the CGRP neurons (red) of the lPBN. Yellow arrows indicate CGRP-
labeled lPBN cell bodies closely apposed by the GLP-1 fibers, while white arrows indicate CGRP-
labeled cell bodies in this region that were not apposed by the GLP-1 fibers. Panel B shows
higher magnification of the lPBN region presented in panel A. Inset in panel B shows the
interaction at a single cell level. Blue color represents DAPI the nuclear stain. Nearly half of the
CGRP-positive cells in the lPBN receive GLP-1 innervation (C) and most cells in the lPBN that were
innervated by GLP-1 fibers were CGRP-positive.
Figure 7. CGRP reduces food intake via a direct action in lPBN. Intra-lPBN delivery of CGRP
reduced chow consumption up to 2h after injections (A). This effect was short lasting since chow
intake (B) and body weight (C) measured 16h after injections were not altered. Data are
expressed as mean SEM. * P  .05.
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munication as even the gustatory PBN displays sensitivity
to themetabolic status, and the lPBN, especially the dorsal
part, is activated by noncaloric gustatory stimuli like sac-
charine (37).Thismaybe the reasonwhyboth caloric food
(chocolate and chow) and noncaloric saccharine con-
sumption were reduced in the current study. Our study
shows that activation of the GLP-1R can suppress intake
of a sweet noncaloric solution.
The PBN plays a critical role in relaying visceral signals
to the forebrain (38).Theparabrachial-associatedeffectof
a gut/brain peptide to reduce food intake, demonstrated
here, fits well with previous studies showing that lPBN
lesion impairs CCK- and amylin-induced food intake sup-
pression and attenuates the c-Fos activation normally ex-
pected fromCCK and amylin action in the central nucleus
of the amygdala (39, 40). Here, we show a direct effect of
GLP-1R in the PBN. This is different from the previous
studies, performed with peripheral injections of CCK and
amylin,which could not determinewhether these peptides
exert direct or indirect feeding effects at the lPBN.
Signaling at the central GLP-1R is necessary for hypo-
phagia induced by satiety andmetabolic signals, like CCK
and leptin, that are recruited in health, but it is also a key
mediator of hypophagia induced by aversive stimuli, like
lithium chloride and lipopolysaccharide (41–43). Inter-
estingly, the same sickness-associated hypophagic stimuli
can activate PBN neurons and this activation may be a
necessary component of the feeding suppression they
cause (44–46).These twocomponents are tied togetherby
data indicating that hindbrain selective blockade of
GLP-1R prevents lipopolysaccharide-induced hypopha-
gia (47). Thus, it is possible that the GLP-1 neuron pro-
jections to the PBN and the hypophagia resulting from
lPBN GLP-1R activation are relevant relays for sickness-
induced hypophagia, and not only for homeostatic appe-
tite during health, as discussed above.
PBN neurons project to the hypothalamus, limbic sys-
tem, and other forebrain regions. In order to begin to un-
derstand the potential downstream circuitry activated by
GLP-1R stimulation in the PBN we determined gene ex-
pression levels for candidate genes recently shown to be
key for appetite suppression in the PBN. We found that
Calca, the gene that encodes CGRP, an anorexic peptide,
was elevated by Ex-4 treatment. CGRP neurons, found
exclusively in the lPBN, play a key role in appetite sup-
pression (18, 48, 49). Optogenetic stimulation of these
neurons suppresses food intake in fed and food deprived
rats. C-Fos studies indicate that these neurons are acti-
vated by satiety signals, like amylin and CCK, and also by
illness inducing signals like lithium chloride and lipopoly-
saccharide. Here, we show that GLP-1R activation can
also stimulateCGRPgene expression.Ourneuroanatomi-
cal and immunohistochemical data suggest that this effect
could be exerted by direct inputs from GLP-1 releasing
fibers onto theCGRP-producing cells, sincewe found that
most NTS-originating GLP-1 producing fibers innervated
CGRP neurons in the lPBN. The elevation of CGRP levels
could contribute to the anorexic and weight suppressing
effect of GLP-1 because direct intra-lPBN injections of
CGRP reduced both food intake and body weight gain. It
is noteworthy that GLP-1R stimulation increased CGRP
only in ad libitum-fed rats, a more physiological situation
for endogenous GLP-1 release. The lack of effect of
GLP-1R activation on CGRP in fasted rats may indicate
that orexigenic signals abundant during fasting may in-
hibit GLP-1s ability to induce CGRP thereby reducing its
ability to suppress food intake. This result is in line with a
previous report showing a nearly complete suppression of
GLP-1 neuron activation by food deprivation (50). Taken
together, the present and previous studies suggest that
fasting can suppress both production/release of GLP-1
and GLP-1-stimulated downstream anorexic pathways.
IL1 and IL6 are key regulators of the inflammatory
response (51, 52) but theymay also play an important role
in healthy animals to regulate metabolic function. Mice
lacking IL1R or IL6 develop late-onset obesity as well as
disturbed glucosemetabolism (53–56). Recently, we iden-
tified IL1 and IL6 as key mediators of the appetite sup-
pressive effects of GLP-1 (28). The results of the current
study complement the previous data by showing that
GLP-1R activation can increase IL6 gene expression not
only in the hypothalamus and caudal brainstembut also in
the PBN. The elevation of IL6 in the PBN was detected
irrespective of the feeding state of the animal indicating
that the relationship between Ex-4 and IL6 is robust. Pre-
vious data link CGRP and IL6 in the pituitary (57). While
our data do not directly examine this connection, CGRP
maynotbenecessary for theEx-4 inductionof IL6because
IL6 levels were elevated in fasted rats while CGRP re-
mained unchanged. IL1 mRNA was not altered in the
PBN, in line with previous data showing that GLP-1 can
induce IL1 in the hypothalamusbut not the caudal brain-
stem (28).
Collectively, this study reveals lPBN as a neural sub-
strate for the feeding suppression effect ofGLP-1and iden-
tifies themechanisms involved (Figure 8). Thismechanism
of action may be relevant to patients receiving Ex-4, or
other GLP-1 analogues, given that these pharmaceuticals
can cross the blood brain barrier after peripheral appli-
cation and c-Fos results indicate that peripheral Ex-4 in-
jections in rodents can activate the PBN (58).
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